Abstract
Purpose: SABR is standard practice for peripheral early stage lung cancer patients' who are medically inoperable. SABR was implemented from July 2014 at our centre. As part of quality reassurance, we analysed the survival outcomes and early toxicity of data in our patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have